BioGenCell’s mission is to develop an innovative technology platform that will enable the rapid creation of easy-to-use and cost-effective treatments for a wide range of degenerative diseases using highly standardized therapies derived from adult stem cells.
Prof. Martin Grajower
Dr. Martin Grajower, MD, is an endocrinology, diabetes & metabolism specialist in Bronx, NY and has been practicing for 40 years. He graduated from Albert Einstein College of Medicine in 1973, is board-certified in both specialties and holds the title of Clinical Associate Professor of Medicine, Division of Endocrinology, at Einstein. Dr. Martin Grajower is the vice president of the Lower New York Chapter of the American Association of Clinical Endocrinologist. He serves on the editorial board of Endocrine Practice and Journal of Hospital Administration, is co-editor of leading scientific publications and is an endocrine consultant to Prescriber’s Newsletter. Dr. Grajower also serves on many national committees, is a fellow of the American College of Physicians and the American college of Endocrinology, is an Affiliate Physician at Columbia University College of Physicians and Surgeons and maintains a leading private practice in New York. Before advising BioGenCell he served as an Advisory Board member to Bristol-Myers Squibb.